NCT05666882 (HIV-IC) is a clinical trial of Non-interventional in HIV Infections, sponsored by Ankara University.

Who is sponsoring NCT05666882?

NCT05666882 is sponsored by Ankara University.

What drugs are being tested in NCT05666882?

Interventions in NCT05666882: Non-interventional.

What condition does NCT05666882 study?

NCT05666882 studies HIV Infections.

Is NCT05666882 still recruiting?

NCT05666882 is currently status unknown. Last updated 28 December 2022.

Last reviewed 2022-12-28 · How we verify

NCT05666882: HIV-IC

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect on the HIV Diagnosis Rates of Integration of AIDS Indicator Conditions Into the Hospital Information Systems

Status unknown Last updated 28 December 2022

What this trial tests

trial testing Non-interventional in HIV Infections in 10,000 participants. Status unknown.

Timeline

1 June 2022

Primary endpoint
30 December 2023

28 February 2024

Quick facts

Lead sponsor	Ankara University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	10,000
Start date	1 June 2022
Primary completion	30 December 2023
Estimated completion	28 February 2024
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

Non-interventional

Conditions studied

HIV Infections — all drugs for HIV Infections →

Sponsor

Ankara University

Who can join

Eligibility, any sex, with HIV Infections. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

to describe the change in the number of HIV diagnosis before and after the integration of the indicator conditions and diseases to hospital automation system

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Non-interventional

Trials testing the same drug.

NCT06798298 — A Safety and Efficacy Long-Term Follow-up Study of Adult Participants Treated With Gene Modified T Cells · recruiting
NCT06746883 — A Study to Assess the Safety and Risk of Hypersensitivity Reactions of Sulbactam-durlobactam in Adults With Acinetobacte · recruiting
NCT06622798 — Exploratory Study on the Correlation Between HRD Score and PARPi Efficacy Based on Chinese Ovarian Cancer Patients · recruiting
NCT06784154 — The Role of Ectopic Fat and Heart Attack Risk in HIV · recruiting
NCT06277037 — Long-Term Follow-up Study for Subjects With CHB Previously Treated With Imdusiran (AB729) · recruiting

Other recruiting trials for HIV Infections

Currently open trials in the same condition.

NCT07225530 — Implementation of Screen, Treat, and Triage for Women Living With HIV in La Romana (iSTAR) · NA · recruiting
NCT07202546 — A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study) · Phase 2 · recruiting
NCT06694753 — Safety and Immunogenicity Study of Three mRNAs Encoding HIV Immunogens in Adult Participants Without HIV and in Overall · Phase 1 · recruiting
NCT07235852 — Pilot Testing Into the Feasibility of the Developed Cognitive Behavioral Therapy Intervention · NA · recruiting
NCT06665646 — Clinical Trial to Evaluate the Safety and Immunogenicity of Hiltonol, Poly-ICLC-adjuvanted CD40.HIVRI.Env (VRIPRO) in Ad · Phase 1 · recruiting

Other Ankara University trials

Trials by the same sponsor.

NCT07441837 — Terbium 161 PSMA in Lutetium-177 PSMA Naive Patients · Phase 2 · not yet recruiting
NCT07536490 — Sleep Quality, Cognition, and Disease Severity in Parkinson's Disease · not yet recruiting
NCT06959433 — Lu-177 PSMA Treatment in Cell Renal Carcinoma · Phase 3 · not yet recruiting
NCT07513272 — EFFECT OF BALLS ON PAIN AND ANXIETY DURING VENIPUNCTURE IN CHILDREN · NA · not yet recruiting
NCT07536542 — Effects of Dual-Task Training on Upper Extremity Function in Parkinson's Disease · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05666882 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ankara University
Last refreshed: 28 December 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05666882.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing